Bahraini Anoosh, Banerjee Oyshik, Ra Jin
University of North Carolina Hospital at Chapel Hill, Chapel Hill, NC 27599, United States of America.
Trauma Case Rep. 2021 Oct 25;36:100548. doi: 10.1016/j.tcr.2021.100548. eCollection 2021 Dec.
Dexmedetomidine is an alpha-2 agonist sedative and analgesic used in anesthesia practice, and it has become more prevalent in the critically ill patients requiring short-term mechanical ventilation. While dexmedetomidine is known to have minimal effects on respiratory drive, it has been well-documented to cause bradycardia and hypotension, especially in patients with existing comorbidities. We present a patient without cardiovascular comorbidities who was in the surgical ICU under dexmedetomidine sedation. The patient went into asystole cardiac arrest after vagal stimulation. Return of spontaneous circulation was achieved using ACLS protocol. We offer a review of reported cases and make recommendations on the management of similar situations that may arise given the increasing use of dexmedetomidine.
右美托咪定是一种用于麻醉实践的α-2激动剂镇静镇痛药,在需要短期机械通气的危重病患者中使用得越来越普遍。虽然已知右美托咪定对呼吸驱动的影响极小,但已有充分文献证明它会导致心动过缓和低血压,尤其是在有现有合并症的患者中。我们报告了一名没有心血管合并症的患者,该患者在外科重症监护病房接受右美托咪定镇静。患者在迷走神经刺激后发生心脏停搏。通过高级心血管生命支持(ACLS)方案实现了自主循环恢复。我们回顾了已报道的病例,并就鉴于右美托咪定使用增加可能出现的类似情况的管理提出建议。